New norms for MNC drug prices
New norms for MNC drug prices

In a move that would prevent MNCs such as GlaxoSmithKline (GSK), Eli Lilly, Roche and Pfizer from selling their drugs at a huge premium in India, the government may soon finalise norms for monitoring prices of costly imported patented medicines for diseases such as diabetes, arthritis, obesity, cancer and heart diseases.

NEWS REVIEW – WORLD
NEWS REVIEW – WORLD

[This article was published in the February 2009 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]

Greek scientists have developed heart attack calculator.

whatsapp--v1